Wisconsin Democrats cross the state line to an Illinois pot shop to roll out their marijuana legalization bill, there's bad news for people who might need the opioid overdose reversal drug naloxone, and more.

The opioid overdose reversal drug naloxone. Supplies are running short after a manufacturing problem. (Creative Commons)

Wisconsin Democrats Unveil Marijuana Legalization Bill—At Illinois Dispensary. Democratic lawmakers crossed the state line to use an Illinois marijuana sales outlet as the backdrop for their rollout of a marijuana legalization bill Tuesday. Rep. Mark Spreitzer (D-Beloit), Rep. David Bowen (D-Milwaukee) and Sen. Melissa Agard (D-Madison) are filing a bill that would legalize the possession of small amounts of marijuana and set up a system of taxed and regulated sales. But the bill's prospects are iffy at best in the GOP-controlled state legislature, which has fended off similar efforts for the past eight years. "However you feel about cannabis use, keeping it illegal isn’t helping anything. It’s only hurting. The people of Wisconsin are ready for legalization," Spreitzer said.

Medical Marijuana

Mississippi Lawmakers "Very, Very Close" to Deal on Medical Marijuana. Senate and House negotiators working on a medical marijuana program to replace the one approved by voters but killed by the state Supreme Court, say they are "very, very close" to having a draft bill that could prompt a special legislative session as early as this month. "I believe we have basically most of the major issues resolved,” said Sen. Kevin Blackwell (R-Southaven), who’s leading the Senate’s medical marijuana work. "… We’re very, very close." Gov. Tate Reeves (R), who has the sole authority to call a special session, has said he is willing to do, but not until the House and Senate have reached broad agreement on a proposal.

Harm Reduction

Naloxone Shortage Looms. Pfizer, the maker of single-dose injectable naloxone, the opioid overdose reversal drug, has halted production of the drug since April because of an unspecified manufacturing issue, and that is making the life-saving drug more difficult to obtain and more expensive in the midst of an opioid overdose crisis that has taken tens of thousands of lives in the last year. Pfizer offers the drug at a discount to a national buyers' club of harm reduction programs, but says it may be February before it can meet demand again. That effectively means the life-saving drug will have to be rationed until then. "Who do you stop supplying? Jennifer Plumb of Utah Naloxone said. "Who do you stop prioritizing? Who do you stop making sure has naloxone?"